Treatment of lung cancer
281 results
113 - 212
Effect of testing for cancer on cancer‐ or venous thromboembolism (VTE)‐related mortality and morbidity in people with unprovoked VTE- Psychosocial interventions for reducing fatigue during cancer treatment in adults
- Palliative endobronchial brachytherapy for non‐small cell lung cancer
- Concurrent chemoradiotherapy in non‐small cell lung cancer
- PI3K/AKT/mTOR inhibitors for advanced or recurrent endometrial cancer
- Systemic corticosteroids for the management of cancer‐related breathlessness (dyspnoea) in adults
Breast cancer - Biosimilar monoclonal antibodies for cancer treatment in adults
- Chemotherapy and supportive care versus supportive care alone for advanced non-small cell lung cancer: Cochrane systematic review
- Chemotherapy with cetuximab versus chemotherapy alone for chemotherapy-naive advanced non-small cell lung cancer: Cochrane systematic review
- Pemetrexed disodium in combination with cisplatin versus other cytotoxic agents or supportive care for the treatment of malignant pleural mesothelioma
Daily multivitamins have minimal, if any, effect on preventing cancer in men and do not affect mortality- Gefitinib for advanced non-small cell lung cancer: Cochrane systematic review
- Melatonin in cancer treatment
- Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases
- Chemotherapy for brain metastases from small cell lung cancer
- Antibody induction therapy for lung transplant recipients
- Intermittent versus continuous androgen suppression for prostatic cancer
- Best first‐line therapy for people with advanced non‐small cell lung cancer, performance status 2 without a targetable mutation or with an unknown mutation status
- Biomedical risk assessment as an aid for smoking cessation
- Prolonged cough in adults
- Targeted therapy for advanced anaplastic lymphoma kinase (ALK)‐rearranged non‐small cell lung cancer
- Myositis
- PSA screening has marginal effect on mortality in European study (ERSPC)
- Adjuvant chemotherapy for resected early-stage non-small cell lung cancer: Cochrane systematic review
- Management of adverse effects of radiotherapy
- Short term benefits for laparoscopic colorectal resection
- Vitamins E and C and selenium do not reduce risk of prostate or total cancer in men
- Anticoagulation for the long‐term treatment of venous thromboembolism in people with cancer
- Anticoagulation for perioperative thromboprophylaxis in people with cancer
- Cardiovascular training versus resistance training for fatigue in people with cancer
- Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy: Cochrane systematic review
- Pharmacological treatments for fatigue associated with palliative care: Cochrane systematic review
- Anticoagulation for the initial treatment of venous thromboembolism in people with cancer
- USPSTF review of the benefits and harms of menopausal hormone therapy
- Platinum versus non‐platinum chemotherapy regimens for small cell lung cancer
- Guidelines for end of life care (ACP)
- Cannabis‐based medicines and medical cannabis for adults with cancer pain
- Cisplatin versus carboplatin in combination with third‐generation drugs for advanced non‐small cell lung cancer
- Organ transplant recipient in primary health care
- Interventions for the management of malignant pleural effusions: a network meta‐analysis
- Carotenoids and omega-3 fatty acids do not reduce risk of advanced AMD
- Second‐line chemotherapy for non‐small cell lung cancer
- Semuloparin reduces VTE in cancer patients but at high cost (SAVE-ONCO)
- Oncological emergencies
- Radiotherapy for early breast cancer: Cochrane systematic review
- Platinum‐containing regimens for triple‐negative metastatic breast cancer
- Antithrombotic therapy for ambulatory patients with multiple myeloma receiving immunomodulatory agents
- Smoking cessation
- Anaesthetic techniques for risk of malignant tumour recurrence
- Prophylactic antibiotics or G(M)‐CSF for the prevention of infections and improvement of survival in cancer patients receiving myelotoxic chemotherapy
- Immunotherapy (excluding checkpoint inhibitors) for stage I to III non‐small cell lung cancer treated with surgery or radiotherapy with curative intent
- Haemoptysis
- Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients
- Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases: Cochrane systematic review
- Chemotherapy for advanced non‐small cell lung cancer in the elderly population
- Chemotherapy versus best supportive care for extensive small cell lung cancer: Cochrane systematic review
- Adverse effects of antineoplastic agents
- Percutaneous ethanol injection for liver metastases
- Granulocyte‐Colony Stimulating Factor (G‐CSF) as an adjunct to antibiotics in the treatment of pneumonia in adults
- Impact of PSA screening on quality of life
- Antibiotics for preventing lower respiratory tract infections in high‐risk children aged 12 years and under
- Telephone interventions for symptom management in adults with cancer
- Immunotherapy for advanced renal cell cancer: Cochrane systematic review
- Delivery of intravenous anti‐cancer therapy at home versus in hospital or community settings for adults with cancer
- Cyclophosphamide for connective tissue disease–associated interstitial lung disease
- Alemtuzumab for patients with chronic lymphocytic leukaemia
- Fewer overall hospital days with use of indwelling pleural catheters vs pleurodesis for malignant effusions
- Epidermal growth factor receptor blockers for the treatment of ovarian cancer
- Microwave coagulation for liver metastases
- Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer
- Platinum‐containing regimens for metastatic breast cancer
- Antibiotic prophylaxis for preventing post solid organ transplant tuberculosis
- Mindfulness‐based stress reduction for women diagnosed with breast cancer
- Alcoholic liver disease (ALD)
- Population screening for cancer
- PET‐CT for assessing mediastinal lymph node involvement in patients with suspected resectable non‐small cell lung cancer
- Infections in immunocompromized children
- Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism
- High‐dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents, and young adults with primary metastatic Ewing sarcoma
- Topical tretinoin may increase all-cause mortality
- Pneumonia
- Deep vein thrombosis
- Nivolumab for adults with Hodgkin's lymphoma (a rapid review using the software RobotReviewer)
- Golimumab for rheumatoid arthritis
- Genetic test results that identify increased risk do not change behavior
- Antifibrinolytic therapy to reduce haemoptysis from any cause